MedPath

Wearable Sensors and Artificial Intelligence for Carbohydrate Counting

Completed
Conditions
Type 2 Diabetes
Interventions
Device: eButton
Device: Continuous Glucose Monitoring (CGM)
Registration Number
NCT05335889
Lead Sponsor
NYU Langone Health
Brief Summary

This is a one-group pilot study where Chinese immigrants who are English speaking with T2D from NYU Langone Health and NYU Brooklyn Family Health Center (Sunset Park) will be recruited.

Detailed Description

To evaluate the estimation accuracy using eButton, researchers will collect carbohydrate data via weighing food by registered dietitian nutritionist (RDN) ("gold standard") (2 days/week at research labs) and food diaries by participants (2 days/week at research labs and 3 days/ week at participant home). Then, the estimated carb grams will be compared head to head among each other. Assessment will be at 0 and 2 weeks, including surveys and qualitative audio interview.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • ≥18 years old
  • Diagnosed with T2D at least one year prior
  • Self-identified as first- or second-generation Chinese immigrants
  • Feel comfortable communicating in English, the reason is that the questionnaires/surveys are validated in English
  • Have a computer and internet connection
Exclusion Criteria
  • Plan frequent travel or vacations or plan to relocate in the next five weeks
  • Have serious diabetes-related complications, physical illness, or mental illness (e.g., schizophrenia, bipolar disorder, or substance abuse) that would preclude participation
  • Have severe cognitive impairments (e.g., dementia, intellectual disability)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Type 2 Diabetes groupeButtonParticipants with Type 2 Diabetes will wear eButton and Continuous Glucose Monitoring (CGM) for 2 weeks and complete food diaries to record carb grams.
Type 2 Diabetes groupContinuous Glucose Monitoring (CGM)Participants with Type 2 Diabetes will wear eButton and Continuous Glucose Monitoring (CGM) for 2 weeks and complete food diaries to record carb grams.
Primary Outcome Measures
NameTimeMethod
Accuracy of Carbohydrate Counting using eButton (absolute error)Day 14

The estimated carb grams using the eButton, gold standard, and participants' food diaries will be compared head to head among each other. The absolute error will be computed: the difference between the estimated value and the gold standard (estimated - gold standard). Bland-Altman plots will be used to examine the level of agreement between eButton and gold standard measurements.

Accuracy of Carbohydrate Counting using eButton (relative error)Day 14

The estimated carb grams using the eButton, gold standard, and participants' food diaries will be compared head to head among each other. The relative error will be computed: the percentage difference between the estimated value relative to the gold standard. Relative errors will be reported using boxplots to allow visual comparison of the distribution and variability in errors across all methods. Bland-Altman plots will be used to examine the level of agreement between eButton and gold standard measurements.

Proportion of participants who are fully compliant with eButton useDay 14

Proportion of participants who are fully compliant with eButton use and proportion of meals evaluated using eButton, with 95% confidence intervals will be qualitatively reported. Perceived usefulness and perceived ease of use will be summarized as mean and standard deviation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NYU Langone Health

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath